Description
Azenta Life Sciences, formerly GENEWIZ NGS solutions can be leveraged for adeno-associated virus (AAV) applications, providing a streamlined approach for AAV cell & gene therapy research. Combined with our proprietary QC process, these solutions enable researchers to verify the integrity of packaged AAV vectors, including inverted terminal repeat (ITR) regions, measure AAV expression after infection, monitor host response, and much more.
Whether you are looking for AAV plasmid sequencing or interested in post-infection solutions, Azenta utilizes the latest technologies on the market, including PacBio® long-read (>10kb) and Illumina® short-read sequencing, to provide custom, in-depth solutions for complex AAV gene therapy applications.